Logo

U.S. FDA Approves Merck’s ENFLONSIA™ (clesrovimab-cfor) for Prevention of Respiratory Syncytial Virus (RSV) Lower Respiratory Tract Disease in Infants Born During or Entering Their First RSV Season - Merck.com

Last Updated: 19.06.2025 00:44

U.S. FDA Approves Merck’s ENFLONSIA™ (clesrovimab-cfor) for Prevention of Respiratory Syncytial Virus (RSV) Lower Respiratory Tract Disease in Infants Born During or Entering Their First RSV Season - Merck.com

June 9, 2025 3:11 pm ET

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced the U.S. Food and Drug Administration (FDA) has ap… [+11553 chars]

RAHWAY, N.J.--(BUSINESS WIRE)--

Trump is going to target known criminals in the country illegally for deportation. The Democrats have vowed to fight him every step of the way. Don't they understand this is one of the issues that cost them the white house, the house and senate?